Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CA Providers > General Practitioners

Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology

Accepting New Patients

(Dr. Emily K. Bergsland, MD)

(244 Ratings)

Specializes in: General Practice and Medical Oncology

University of Minnesota Medical School

Professional interests include: stomach cancer, esophageal cancer, rectal cancer, and more.

1825 4th Street
San Francisco, CA 94143

(415) 476-2212

Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology is a general practitioner in San Francisco, CA specializing in general practice and medical oncology. She graduated from University of Minnesota Medical School. Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology is affiliated with UCSF Health, Brown and Toland Physicians, Hill Physicians and Center for Neuroendocrine Tumors.

Office Locations

1825 4th Street
San Francisco, CA 94143

open_in_new

1825 FOURTH STREET FOURTH FLOOR
SAN FRANCISCO, CA 94158

open_in_new

1825 4th Street Floor 4
San Francisco, CA 94143

open_in_new

Hill Physicians

1600 Divisadero Street Suite 4
San Francisco, CA 94115

(415) 353-9888

open_in_new

In The News (see more mentions in the news)

“In addition, she was treated for more than 14 years by amazing doctors, nurses, surgeons, and staff at the UCSF Center for Neuroendocrine Tumors (headed by Dr. Emily Bergsland).”—"Nancy Christine McNeil", East Bay Times, November 2023

“In lieu of flowers the family requests that donations in memory of Colleen Kraus be made to support Dr. Emily Bergsland's research at UCSF.”—"Colleen P. Kraus", East Bay Times, March 2022

“In particular we wish to thank Emily Bergsland and Nicolas Fidelman at UCSF, the stroke center team at Good Samaritan Hospital in Los Gatos, CA, the medical and hospital team at Dominican Hospital...”—"Dorothy Irene Petersen", Mercury News, April 2015

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

Volume of procedures performed by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology for Medicare patients.

doctor visit	155

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

Volume of procedures performed by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology for Medicare patients.

doctor visit	195

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology.

**Gender**
Male	42
Female	46

**Ethnicity**
Non-Hispanic White	61
Black	0
Hispanic	0
Asian	11
Other	0
Native American	0

**Age**
From 65 to 74	50
From 75 to 84	17
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2013

Hypertension	66
High Cholesterol	41
Stroke	0
Ischemic Heart Disease	35
Depression	24
Chronic Kidney Disease	27
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	28
Dementia	0
Cancer	42

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

Volume of procedures performed by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology for Medicare patients.

doctor visit	198

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology.

**Gender**
Male	53
Female	53

**Ethnicity**
Non-Hispanic White	78
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	63
From 75 to 84	27
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2014

Hypertension	63
High Cholesterol	43
Stroke	0
Ischemic Heart Disease	33
Depression	25
Chronic Kidney Disease	25
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	11
Chronic Obstructive Pulmonary Disease	0
Diabetes	27
Dementia	0
Cancer	43

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

Volume of procedures performed by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology for Medicare patients.

doctor visit	237

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology.

**Gender**
Male	112
Female	108

**Ethnicity**
Non-Hispanic White	170
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	128
From 75 to 84	50
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2015

Hypertension	65
High Cholesterol	47
Stroke	0
Ischemic Heart Disease	29
Depression	23
Chronic Kidney Disease	22
Asthma	0
Osteoperosis	0
Atrial Fibrilation	10
Heart Failure	10
Chronic Obstructive Pulmonary Disease	0
Diabetes	25
Dementia	0
Cancer	34

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

Volume of procedures performed by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology for Medicare patients.

doctor visit	262

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology.

**Gender**
Male	72
Female	58

**Ethnicity**
Non-Hispanic White	100
Black	0
Hispanic	0
Asian	12
Other	0
Native American	0

**Age**
From 65 to 74	73
From 75 to 84	30
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2016

Hypertension	63
High Cholesterol	42
Stroke	0
Ischemic Heart Disease	25
Depression	20
Chronic Kidney Disease	32
Asthma	10
Osteoperosis	0
Atrial Fibrilation	9
Heart Failure	10
Chronic Obstructive Pulmonary Disease	0
Diabetes	28
Dementia	0
Cancer	31

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

Volume of procedures performed by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology for Medicare patients.

doctor visit	275

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology.

**Gender**
Male	73
Female	66

**Ethnicity**
Non-Hispanic White	102
Black	0
Hispanic	0
Asian	11
Other	0
Native American	0

**Age**
From 65 to 74	84
From 75 to 84	32
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2017

Hypertension	64
High Cholesterol	38
Stroke	0
Ischemic Heart Disease	22
Depression	14
Chronic Kidney Disease	37
Asthma	0
Osteoperosis	9
Atrial Fibrilation	0
Heart Failure	9
Chronic Obstructive Pulmonary Disease	0
Diabetes	27
Dementia	0
Cancer	25

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

Volume of procedures performed by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology for Medicare patients.

doctor visit	260

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology.

**Gender**
Male	71
Female	72

**Ethnicity**
Non-Hispanic White	107
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	85
From 75 to 84	38
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2018

Hypertension	62
High Cholesterol	52
Stroke	0
Ischemic Heart Disease	22
Depression	23
Chronic Kidney Disease	34
Asthma	8
Osteoperosis	11
Atrial Fibrilation	11
Heart Failure	10
Chronic Obstructive Pulmonary Disease	0
Diabetes	28
Dementia	8
Cancer	21

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

Volume of procedures performed by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology for Medicare patients.

doctor visit	253

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology.

**Gender**
Male	73
Female	79

**Ethnicity**
Non-Hispanic White	126
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	89
From 75 to 84	38
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2019

Hypertension	59
High Cholesterol	43
Stroke	0
Ischemic Heart Disease	25
Depression	22
Chronic Kidney Disease	37
Asthma	0
Osteoperosis	7
Atrial Fibrilation	10
Heart Failure	13
Chronic Obstructive Pulmonary Disease	7
Diabetes	30
Dementia	8
Cancer	21

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

Volume of procedures performed by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology for Medicare patients.

doctor visit	298

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology.

**Gender**
Male	82
Female	79

**Ethnicity**
Non-Hispanic White	130
Black	0
Hispanic	0
Asian	11
Other	0
Native American	0

**Age**
From 65 to 74	86
From 75 to 84	48
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2020

Hypertension	57
High Cholesterol	45
Stroke	0
Ischemic Heart Disease	24
Depression	22
Chronic Kidney Disease	35
Asthma	0
Osteoperosis	9
Atrial Fibrilation	11
Heart Failure	16
Chronic Obstructive Pulmonary Disease	9
Diabetes	29
Dementia	0
Cancer	16

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

Volume of procedures performed by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology for Medicare patients.

doctor visit	333

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology.

**Gender**
Male	84
Female	81

**Ethnicity**
Non-Hispanic White	132
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	80
From 75 to 84	59
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2021

Hypertension	59
High Cholesterol	50
Stroke	0
Ischemic Heart Disease	27
Depression	24
Chronic Kidney Disease	41
Asthma	0
Osteoperosis	10
Atrial Fibrilation	12
Heart Failure	20
Chronic Obstructive Pulmonary Disease	8
Diabetes	30
Dementia	0
Cancer	21

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

Volume of procedures performed by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology for Medicare patients.

doctor visit	255

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology.

**Gender**
Male	82
Female	74

**Ethnicity**
Non-Hispanic White	125
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	76
From 75 to 84	53
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2022

Hypertension	63
High Cholesterol	60
Stroke	0
Ischemic Heart Disease	21
Depression	18
Chronic Kidney Disease	22
Asthma	9
Osteoperosis	15
Atrial Fibrilation	17
Heart Failure	14
Chronic Obstructive Pulmonary Disease	10
Diabetes	34
Dementia	0
Cancer	25

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology for Medicare patients.

doctor visit	247

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology.

**Gender**
Male	67
Female	65

**Ethnicity**
Black / African American	0
Asian / Pacific Islander	4
Non-Hispanic White	102
Native American / Alaskan Native	0
Hispanic	0
Other	0

**Age**
75 to 84	35
85 and over	0
Less than 65	0
65 to 74	74

Average of Total of Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology treated were hypertension, high cholesterol, chronic kidney disease and cancer.

Hypertension	56
High Cholesterol	41
Stroke	0
Ischemic Heart Disease	23
Depression	19
Chronic Kidney Disease	28
Asthma	2
Osteoporosis	5
Heart Failure	10
Chronic Obstructive Pulmonary Disease	3
Diabetes	26
Atrial Fibrillation	7
Dementia	1
Cancer	25

Education & Training

Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology graduated from University of Minnesota Medical School. She completed residency at University of California, San Francisco (UCSF) Affiliated Hospitals. She is certified by the American Board of Internal Medicine: Hematology and has a state license in California.

Medical School: University of Minnesota Medical School

Residency: University of California, San Francisco (UCSF) Affiliated Hospitals

Board Certification: American Board of Internal Medicine: Hematology

Licensed In: California

Affiliations & Hospitals

Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology is associated with these hospitals and organizations:

UCSF Health

Brown and Toland Physicians

Hill Physicians

Center for Neuroendocrine Tumors

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology appears to accept the following insurance providers: Cigna, Aetna, Blue Shield of California, UnitedHealthcare, SCAN Health Plan, Anthem, Health Net, Hill Physicians Care Solutions, Central Health Plan, CCHP Health Plan (Chinese Community Health Plan) and Canopy Health.

Insurance Accepted by Provider includes:

According to our sources, Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology accepts the following insurance providers:

Cigna

Aetna

Blue Shield of California

UnitedHealthcare

SCAN Health Plan

Anthem

Health Net

Hill Physicians Care Solutions

Central Health Plan

CCHP Health Plan (Chinese Community Health Plan)

Canopy Health

Ratings & Reviews

Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology has an exceptional overall rating with an average of 4.92 out of 5 stars based on 244 ratings. We collect ratings and reviews of Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology from all over the web to help you find the right in San Francisco, CA.

4.92

Overall Rating

(244 Ratings)

Leave a Review

Reviews From Around The Web

Overall Rating: 5.0 2025-02-08

Patient verified via Press Ganey

Dr. Bergsland is exceptional

General Payments

These charts describe general payments received by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Novartis Pharmaceuticals Corporation	$1,805 AFINITOR $1,212	ZYKADIA $471	SANDOSTATIN LAR $123
Ipsen Biopharmaceuticals, Inc	$871 Somatuline Depot 120mg-.5ml $871
Boehringer Ingelheim International GmbH	$299 $299
Celgene Corporation	$208 None $208
Ipsen Pharma SAS	$200 $200
Other	$573 Cabometyx $176	LUTATHERA (lutetium LU 177 dotatate) $151	Avastin $107	SIR-Spheres microspheres $60	Actemra $38	Other $40

**Types of Payments**
Food and Beverage	$1,867
Travel and Lodging	$1,590
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$299
Consulting Fee	$200

Research Payments

Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology has received 83 research payments totaling $4,825,267.

Biography

Dr. Emily Bergsland's medical specialty is general practice and medical oncology. These areas are among Dr. Bergsland's clinical interests: esophageal cancer, rectal cancer, and stomach cancer. She has received a 5.0 out of 5 star rating by her patients. She accepts Blue Shield, Health Net, Anthem, and more. Dr. Bergsland graduated from the University of Minnesota Medical School and then she performed her residency at a hospital affiliated with the University of California, San Francisco (UCSF). Her hospital/clinic affiliations include UCSF Medical Group, Brown and Toland Physicians, and Hill Physicians. Her practice in San Francisco, CA is open to new patients as reported by Hill Physicians.

Select Year:

Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology

Office Locations

In The News (see more mentions in the news)

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

2013 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2013

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

2014 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2014

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

2015 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2015

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

2016 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2016

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

2017 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2017

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

2018 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2018

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

2019 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2019

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

2020 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2020

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

2021 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2021

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

2022 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology in 2022

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Average Medicare Patient Data From 2012 - 2022

Average of Total of Conditions of Medicare patients treated by Dr. Emily K. Bergsland, MD, Gastrointestinal Medical Oncology | Neuroendocrine Oncology From 2012 - 2022

Education & Training

Affiliations & Hospitals

Insurance Information

Ratings & Reviews

General Payments

Research Payments

Biography

General Practitioners in Nearby Locations

Other Providers in San Francisco, CA